Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

Screening for coronary artery disease in respiratory patients: comparison of single- and dual-source CT in patients with a heart rate above 70 bpm

“…Investigating 133 patients with a regular sinus rhythm who did not receive betablockers, Salem et al found that both morphological and functional information could be obtained from the same data set in 92% of the population studied with singlesource MDCT [41]. These recent experiences suggest that respiratory patients can now benefit from cardiothoracic imaging, a concept worth considering in the management of patients with chronic obstructive pulmonary disease (COPD) in whom coronary arteries represent a well-known target of systemic inflammation [42][43][44]. Because chest CT is a frequent indication in the above-mentioned populations, it is of clinical importance to demonstrate that high heart rates are no longer contraindications for ECG-gated CT angiograms of the chest.…”

Chronic obstructive pulmonary disease severity and cardiovascular outcomes

“…Patients with impaired pulmonary function have an elevated risk of cardiovascular disease [1][2][3][4]. A study in the Saskatchewan population provided evidence that the prevalence of cardiovascular diseases and incidence of hospitalization due to cardiovascular diseases is higher among patients with chronic obstructive pulmonary disease (COPD) [5].…”

“…Additionally, severity graded using forced expiratory volume (FEV) and forced expiratory volume in one second (FEV 1 ), similar to the GOLD guidelines, has been shown to be related to functional limitations such as inability to walk a quarter of a mile [9]. FEV 1 has also been shown to be related to cardiovascular outcomes [3], and low FEV 1 levels have been shown to predict mortality among patients with obstructive lung disease [10].…”

COPD, eine Systemerkrankung?ern�hrungstherapeutische Ans�tze

“…Muskeln (s.u. ), Gefäße [60] und Knochen (s.u.). Häufige Exazerbationen führen zu einer rasanten Verschlechterung der Lungenfunktion und verstärken die systemischen Effekte.…”